Sail Biomedicines’ Post

There is no doubt that CRISPR technology and AI are both making huge breakthroughs in genetic medicine. This article is interesting as it highlights the impact of combining the two. AI's ability to quickly improve gene-editing tools and speed up drug development could bring new treatments to people who need them even sooner. It’s exciting to see how these technologies are working together to make a real difference in healthcare. https://lnkd.in/eHjmN2Qj

Introducing OpenCRISPR-1: Profluent's AI gene editor. CEO Ali Madani sees AI as the future of medicine, sharing to accelerate cures globally. #OpenCRISPR #AI #geneediting #Profluent #AliMadani #medicine #futureofmedicine

You’ve heard AI is changing medical science. Now, there’s an Open Source gene editor with the power to edit human DNA. https://lnkd.in/e6j2fJjK #OpenCRISPR-1 # Profluent #AI #HumanGenome #Healthcare #OIN

Initially, #precisionmedicine primarily focused on genetic factors to tailor treatments to individual patients. In recent years, the landscape has expanded to #AI and #ML that now play a pivotal role in analyzing massive datasets, enabling more precise diagnostics and personalized treatment plans. Speaking on this paradigm shift is our CCO Chris Dingman & other top players in the field. #personalizedmedicine #proteomics #machinelearning

Betazone: Keeping AI on Track with Erik Brynjolfsson and Zeina Soufan #GFC24 From bespoke gene editing to #AI-powered #healthcare, we are living in an age of breakthroughs propelled by advances in AI. What are the trade-offs societies and industries need to manage as AI adoption progresses?

🚀 Stanford Institute for Human-Centered Artificial Intelligence (HAI) professor Erik Brynjolfsson on 4 things we are getting wrong about AI: 🤖 1️⃣ The goal of AI shouldn't be to imitate human intelligence. That's too narrow. Instead, AI should be used for what machines excel at that humans don't. 💡 2️⃣ There's an amazing gap between technology improvements and institutional adaptation. We need to close that gap by investing more in economics, policy, and understanding the societal implications of AI. 🏛️📊 3️⃣ AI may not immediately improve productivity, but once companies establish new processes and understand the tech, productivity will take off. 📈 4️⃣ The future of AI is not inevitable. AI is a powerful tool, but our choices will shape its direction. Policymakers can set the goals to steer AI toward positive outcomes. ⚖️🔮 What do you think? #AI #Technology #FutureOfWork #Policymaking #Innovation

Wall Street analysts optimistic about genetic testing company Tempus AI To know more about it read our full article here: https://lnkd.in/dW4VKd-T . . . . #cionews #newsdesk #dailynews #trending #TempusAI #GeneticTesting #WallStreet #AnalystOpinion #BiotechInvesting #HealthTech #AIInHealthcare #StockMarket #InvestmentNews #IndustryAnalysis

𝗠𝗮𝗸𝗲 𝘆𝗼𝘂𝗿 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀-𝗱𝗿𝗶𝘃𝗲𝗻, 𝘀𝗺𝗮𝗿𝘁𝗲𝗿, 𝗮𝗻𝗱 𝗳𝗮𝘀𝘁𝗲𝗿 𝘄𝗶𝘁𝗵 𝗔𝗜.   Omics technologies, encompassing #genomics, #proteomics, and #metabolomics, generate vast data, but analyzing and identifying meaningful targets remains time-consuming. In this blog, Dr. Manasi Tukdeo shares her insights on how generative AI helps multi-omics research.   Gene Inspector employs Multiple Agents—Correlation Agents, Harmonization Agents, and Interactive Agents—to automate tedious tasks and deliver ranked, validated targets in multi-omics research.   Learn More - https://lnkd.in/gruCSSJY #Omics #GenerativeAI #LifeSciences #DataAnalysis #GeneInspector #Healthcare #Insights #TargetIdentification

If you’ve played with ChatGPT, you’ve interacted with a Large Language Model (LLM). But what do #LLMs have to do with biology? LLMs can be trained on biological data – like DNA, amino acid sequences, and gene expression profiles – in order to extract important signals and patterns. In our latest blog, we explore different ways these models can be used to advance research in areas like #genomics, #proteomics, #drugdiscovery, and more. Read the full blog here: https://lnkd.in/eTz5h6MQ #machinelearning #biopharma #AI

Are you aware of the strategic imperatives driving transformation in precision health? 🤔 Discover how AI is transforming precision health by harnessing generative AI for personalized medicine, accelerating drug discovery, and enhancing gene editing.⚕️ Learn about industry convergence and competitive intensity driving these changes. 🔗https://hubs.la/Q02GHtJd0 #PrecisionHealth #AIinHealthcare #GenerativeAI #DrugDiscovery #GeneEditing #Telehealth #HealthcareInnovation Sherin George | Robin Joffe | Nimisha Iyer | Nitin Naik | Unmesh Lal | Shylesh Narayanan | Tamer Abu Elhassan | Mark D. | Abdulaziz Jalab | Arun Stanly | Hani Al Sayed